CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-12 | Tubridy Karen L SVP, Chief Development Officer | Shares withheld for taxes | −11,928 | $8.94 | $107K | 30,229 |
| 2018-12-12 | Jain Rita SVP, Chief Medical Officer | Shares withheld for taxes | −8,659 | $8.94 | $77K | 20,741 |
| 2018-12-12 | Hadas Nicole R. SVP, General Counsel, Sec. | Shares withheld for taxes | −20,175 | $8.94 | $180K | 101,284 |
| 2018-12-12 | Dahan Michel SVP, Chief Business Officer | Shares withheld for taxes | −23,385 | $8.94 | $209K | 93,841 |
| 2018-12-12 | Butler John P. CEO & President | Shares withheld for taxes | −135,697 | $8.94 | $1.2M | 374,617 |
Page 21 of 21 · 405 trades